GeoWealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-19
Closed -$1.05K – 1093
2024
Q4
$1.05K Sell
19
-10
-34% -$574 ﹤0.01% 1695
2024
Q3
$1.73K Buy
+29
New +$1.77K ﹤0.01% 1563

Other funds holding ANIP

GeoWealth Management's ANIP Position: Q1 2025 in Review

GeoWealth Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2025, closing a stake of 19 shares — an estimated $1.05K sold.

GeoWealth Management first reported a position in ANIP in Q3 2024 and held it in 2 quarters. The position peaked at $1.73K in Q3 2024. 230 funds tracked by Wall St. Rank hold ANIP as of Q1 2025.

  • GeoWealth Management reported no remaining ANI Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • GeoWealth Management sold 19 ANI Pharmaceuticals shares in Q1 2025, an estimated $1.05K.
  • GeoWealth Management first reported a position in ANI Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • GeoWealth Management's ANI Pharmaceuticals position peaked at $1.73K in Q3 2024.
  • 230 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2025.

Based on GeoWealth Management's 13F filing for Q1 2025, filed 9 May 2025.